GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo treatment trial aims to stop stomach Cancer's return
Disease control OngoingThis study is comparing two treatment approaches for patients with a specific type of stomach or gastroesophageal junction cancer that has not spread widely. The goal is to see if using an immunotherapy drug (atezolizumab) combined with chemotherapy before and after surgery works…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to boost immune system against stomach and esophageal cancers
Disease control TerminatedThis study is testing whether adding two immunotherapy drugs, nivolumab and ipilimumab, to standard chemotherapy and radiation can better treat certain cancers of the esophagus and stomach junction. It involves patients who are scheduled for surgery. The goal is to see if this co…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo tested to shrink tumors before stomach cancer surgery
Disease control OngoingThis study is testing whether adding a new immunotherapy drug (atezolizumab) to a standard chemotherapy and targeted therapy combination works better before surgery for people with a specific type of stomach or gastroesophageal cancer (HER2-positive). The goal is to shrink the tu…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients test promising new weapon against tough cancers
Disease control OngoingThis is the first time a new drug called TORL-2-307-ADC is being tested in people. The main goal is to find a safe dose and see how the body handles it in 163 patients with advanced solid tumors, including stomach and pancreatic cancer. Researchers will also look for early signs …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for tough stomach cancers: advanced drug trial seeks to extend lives
Disease control OngoingThis study is testing an experimental drug called trastuzumab deruxtecan for people with advanced HER2-positive stomach or gastroesophageal cancer that has continued to grow despite initial treatment. It will compare this new drug against a standard combination therapy to see whi…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Targeted drug trial aims to extend lives in advanced stomach cancer
Disease control OngoingThis study is testing whether adding a new targeted drug called bemarituzumab to standard chemotherapy helps people with advanced stomach or gastroesophageal cancer live longer. It is for adults with a specific biomarker (FGFR2b) in their tumor who have not yet received treatment…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Breakthrough combo targets aggressive stomach cancers
Disease control OngoingThis large Phase 3 trial is testing whether adding an experimental drug called ASKB589 to standard chemotherapy and immunotherapy works better for people with advanced stomach or gastroesophageal cancer. The study involves 780 patients in China who have a specific biomarker calle…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE3 • Sponsor: AskGene Pharma, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope: testing powerful drug duo to fight tough cancers
Disease control OngoingThis study is testing whether adding two new immunotherapy drugs, durvalumab and tremelimumab, to standard chemotherapy and radiation is safe and effective for treating esophageal and gastroesophageal junction cancer. The trial involves 64 patients who will receive the drug combi…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New hope for tough stomach cancers: targeted drug enters final testing
Disease control OngoingThis study is testing whether adding a new targeted drug called bemarituzumab to standard chemotherapy and immunotherapy helps people with advanced stomach or gastroesophageal cancer live longer. It's for adults with a specific tumor marker (FGFR2b) who haven't had treatment for …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC
-
New Two-Pronged attack on advanced stomach cancer
Disease control OngoingThis trial is testing a two-step treatment for stomach or gastroesophageal cancer that has spread to the abdominal lining. First, patients receive standard chemotherapy. If the cancer hasn't spread to other organs, they then receive a second type of chemotherapy delivered directl…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Mar 02, 2026 15:23 UTC
-
Hot chemo bath during surgery aims to stop stomach Cancer's return
Prevention ENROLLING_BY_INVITATIONThis study is testing a new approach to prevent stomach cancer from returning to the abdominal cavity after surgery. During the operation, doctors will wash the abdomen with a warm chemotherapy solution. The goal is to kill any stray cancer cells left behind to prevent the cancer…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Virtual diet coach aims to ease eating struggles after stomach cancer surgery
Symptom relief OngoingThis study is testing whether a telehealth diet coaching program helps people eat better and feel better after surgery for stomach or esophageal cancer. About 53 participants were randomly assigned to receive either four virtual coaching sessions or standard nutritional support. …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC